MP asks government to authorise local manufacture of drug for rare disease to slash cost

A Rajya Sabha MP urges the health minister to enable local production of Risdiplam, a vital drug for spinal muscular atrophy, to reduce costs. Current patents prevent affordable production. Encouraging local manufacturing could make the drug accessible at significantly reduced prices, benefiting thousands of patients in India.
|
||||
|
||||
You Might Like💡 newsR Knowledge: Other News Mentions
|
Budget 2025: FM Nirmala Sitharaman to table economic survey after President's address on Jan 31The Finance Minister will table the Economic Survey on Friday when both Lok Sabha and Rajya Sabha will convene briefly after the President's address.DNA |
'Delhi loves you': Arvind Kejriwal shares throwback picture to wish Manish Sisodia on his birthdayFormer Delhi chief minister and AAP leader Arvind Kejriwal wishes happy birthday to his colleague and ex-deputy CM Manish Sisodia, lauding his contributions to...IndiaTimes |
MP asks government to authorise local manufacture of drug for rare disease to slash costA Rajya Sabha MP urges the health minister to enable local production of Risdiplam, a vital drug for spinal muscular atrophy, to reduce costs. Current patents...IndiaTimes |